透過您的圖書館登入
IP:3.134.253.166

摘要


2022年5月以來,台灣本土新冠肺炎疫情大爆發,為保全醫療量能,政府宣布確診患者依輕重症分流原則收治並擴大辦理「視訊診療照護」。台灣中醫基層醫療機構(診所)因應疫情發展,參與分流收治輕症患者,此舉改變了過去台灣民眾對於中醫門診的醫療行為與認知。為剖析病患於此次新冠疫情之醫療行為以及新冠肺炎症狀於中醫藥輔助下之變化,我們以問卷形式共募集了1404名病患進行研究。給予中藥處方後,病患前後的症狀變化,可供醫師針對輕症急性期以及新冠後遺症患者之臨床治療參考。我們的研究結果指出在使用中藥後,高達87.6%的病患同意「病情進步」;此外,「經過此次的用藥經驗,若未來身體不適,會選擇使用中醫藥」的意願佔89.5%;而94.5%的病患認為「視訊診療對自己有幫助」。整體而言,病患對於此次中醫分流的輔助診療滿意度極高,未來亦很願意就診中醫。

並列摘要


The pandemic of Coronavirus Disease 2019 (COVID-19) has broken out in Taiwan since May 2022. In order to preserve the medical capacity, the government announced that the patients with confirmed diagnosis of COVID-19 will be admitted and treated according to the principle of triage. The "telemedicine and virtual appointment" will be hold and used for patients with mild symptoms. In response to the outbreak of the pandemic, TCM(Traditional Chinese Medicine) primary medical institutions (clinics) participated in the admission of patients with mild symptoms and provided the treatment for them, which changed the behavior and cognition of people towards TCM clinics. To investigate the behavior of patients during the COVID-19 pandemic and the changes in the symptoms of COVID-19 after the treatment of traditional Chinese medicine, a total of 1404 patients were enrolled to participate in this study and were evaluated using the questionnaire. The change of symptoms in patients after the treatment of TCM prescription collected in this study can be used as reference by physicians for future clinical treatment in patients with mild acute stage of COVID-19 and its sequelae. Our results indicate that after TCM treatment, up to 87.6% of the patients agree with the "improvement of the disease"; in addition, 89.5% of the patients are willing to use traditional Chinese medicine after this medication experience, and 94.5% of the patients believed that telemedicine consultation was helpful. Taken together, the patients were very satisfied with the auxiliary treatment of TCM and are willing to have TCM treatment in the future.

參考文獻


Chen J, Wei GW. Omicron BA.2 (B.1.1.529.2): High potential to becoming the next dominating variant. J Phys Chem Lett. 2022; 13(17): 3840-3849.
Singhal T. The Emergence of Omicron: Challenging Times Are Here Again! Indian J Pediatr. 2022; 89(5):490-496.
衛生福利部國家中醫藥研究所,《新型冠狀病毒病中醫臨床分期治療指引》公告。中醫藥雜誌 2020;31(1):1-3。
健保署,因應 COVID-19 疫情全民健康保險特約醫事服務機構提供保險對象視訊診療作業須知。20220502 第六版。取自:https://www.nhi.gov.tw/Content_List.aspx?n=1482911120B73697&topn=787128DAD5F71B1A。
行政院衛生福利部疾病管制署,新型冠狀病毒 SARS-CoV-2 感染臨床處置指引第十九版,20220526,取自:https://www.cdc.gov.tw/File/Get/ZA_eJYJTL7Zy0kVG7f24Qg。

延伸閱讀